← back to search

Di Wu

Shanghai Medical College of Fudan University · CN
Area of research
Reproductive Medicine · Obstetrics and Gynecology
Research interest
Research interests include Medicine, Biology, Lung cancer, Oncology, Chemotherapy, and Intensive care medicine.
h-index
citations
472
works
9
NIH funding
primary concept
email

Recent publications

Expert consensus on cancer treatment-related lung injury
Journal of Thoracic Disease 2025cited by 4position: middledoi
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
Nature Medicine 2024cited by 115position: middledoi
Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial
Signal Transduction and Targeted Therapy 2024cited by 33position: middledoi
Association between the oxidative balance score and thyroid function: Results from the NHANES 2007–2012 and Mendelian randomization study
PLoS ONE 2024cited by 10position: middledoi
Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer
Heliyon 2024cited by 9position: middledoi
Quality of life in ovarian cancer patients treated with bevacizumab: a meta-analysis
Expert Opinion on Drug Safety 2023cited by 5position: firstdoi
Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker
Journal of Cancer Research and Clinical Oncology 2023cited by 2position: middledoi
Notch signaling: Its essential roles in bone and craniofacial development
Genes & Diseases 2020cited by 79position: middledoi
The wonders of BMP9: From mesenchymal stem cell differentiation, angiogenesis, neurogenesis, tumorigenesis, and metabolism to regenerative medicine
Genes & Diseases 2019cited by 126position: middledoi
Stem cell therapy for chronic skin wounds in the era of personalized medicine: From bench to bedside
Genes & Diseases 2019cited by 75position: middledoi
Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells
ACS Synthetic Biology 2019cited by 29position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2024–2024)Liming Chen · Zhejiang University1 papers (2024–2024)Minting Ma · Fourth Hospital of Hebei Medical University1 papers (2024–2024)Shuai Hao · Xi'an University of Science and Technology1 papers (2024–2024)Zirong Wang · BGI Group (China)1 papers (2023–2023)Wen‐Feng Fang · East China Jiaotong University1 papers (2024–2024)Feifan Fu · Shanxi Medical University1 papers (2024–2024)Qingsong Guo · Nantong University1 papers (2023–2023)Huaqiang Zhou · Genecast (China)1 papers (2024–2024)Xiaoling Chen · Nantong University1 papers (2024–2024)Qian Yang · Leshan Normal University1 papers (2024–2024)Jian Fang · Wenzhou Medical University1 papers (2024–2024)Haonan Zhou · Ministry of Education of the People's Republic of China1 papers (2024–2024)Xin Xiao Zheng · Nantong University1 papers (2024–2024)Li Zhang · Central South University1 papers (2024–2024)Guowu Wu · Meizhou City People's Hospital1 papers (2024–2024)Qianyun Hao · Zhengzhou University1 papers (2024–2024) · 1 papers (2024–2024)Dongzhi Wang · Nantong University1 papers (2023–2023)Yuhua Lu · Wake Forest University1 papers (2023–2023)